112 related articles for article (PubMed ID: 9771693)
21. Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells.
Castro AG; Hauser TM; Cocks BG; Abrams J; Zurawski S; Churakova T; Zonin F; Robinson D; Tangye SG; Aversa G; Nichols KE; de Vries JE; Lanier LL; O'Garra A
J Immunol; 1999 Dec; 163(11):5860-70. PubMed ID: 10570270
[TBL] [Abstract][Full Text] [Related]
22. Expression of signaling lymphocytic activation molecule-associated protein interrupts IFN-gamma production in human tuberculosis.
Pasquinelli V; Quiroga MF; Martínez GJ; Zorrilla LC; Musella RM; Bracco MM; Belmonte L; Malbrán A; Fainboim L; Sieling PA; García VE
J Immunol; 2004 Jan; 172(2):1177-85. PubMed ID: 14707094
[TBL] [Abstract][Full Text] [Related]
23. Gene mutation responsible for fatal EBV complication discovered.
McCarthy M
Lancet; 1998 Oct; 352(9134):1125. PubMed ID: 9798601
[No Abstract] [Full Text] [Related]
24. The abnormal gene in X-linked lymphoproliferative syndrome.
Sullivan JL
Curr Opin Immunol; 1999 Aug; 11(4):431-4. PubMed ID: 10448142
[TBL] [Abstract][Full Text] [Related]
25. SAP: a molecular switch regulating the immune response through a unique signaling mechanism.
Veillette A
Eur J Immunol; 2003 May; 33(5):1141-4. PubMed ID: 12731038
[No Abstract] [Full Text] [Related]
26. The cell surface expression of SAP-binding receptor CD229 is regulated via its interaction with clathrin-associated adaptor complex 2 (AP-2).
Del Valle JM; Engel P; Martín M
J Biol Chem; 2003 May; 278(19):17430-7. PubMed ID: 12621057
[TBL] [Abstract][Full Text] [Related]
27. SLAM the door on measles.
Brooksbank R
Mol Med Today; 2000 Nov; 6(11):414. PubMed ID: 11074361
[No Abstract] [Full Text] [Related]
28. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition.
Poy F; Yaffe MB; Sayos J; Saxena K; Morra M; Sumegi J; Cantley LC; Terhorst C; Eck MJ
Mol Cell; 1999 Oct; 4(4):555-61. PubMed ID: 10549287
[TBL] [Abstract][Full Text] [Related]
29. Genomic organization and characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease.
Wu C; Sayos J; Wang N; Howie D; Coyle A; Terhorst C
Immunogenetics; 2000 Aug; 51(10):805-15. PubMed ID: 10970095
[TBL] [Abstract][Full Text] [Related]
30. X-linked lymphoproliferative disease with a novel SH2D1A gene mutation.
Debeljak M; Podkrajsek KT; Aplenc R; Jazbec J
Pediatr Blood Cancer; 2008 Jan; 50(1):187. PubMed ID: 17455312
[No Abstract] [Full Text] [Related]
31. Manifestations of X-linked lymphoproliferative disease without prior Epstein-Barr exposure.
Schuster V; Steppberger K; Borte M
Blood; 2001 Sep; 98(6):1986-7. PubMed ID: 11565537
[No Abstract] [Full Text] [Related]
32. Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).
Nalesnik MA
Springer Semin Immunopathol; 1998; 20(3-4):325-42. PubMed ID: 9870249
[No Abstract] [Full Text] [Related]
33. Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.
O'Reilly RJ; Lacerda JF; Lucas KG; Rosenfield NS; Small TN; Papadopoulos EB
Important Adv Oncol; 1996; ():149-66. PubMed ID: 8791134
[No Abstract] [Full Text] [Related]
34. [The cellular receptor for measles virus: SLAM (CDw 150)].
Tatsuo H; Ono N; Tanaka K; Yanagi Y
Uirusu; 2000 Dec; 50(2):289-96. PubMed ID: 11276818
[No Abstract] [Full Text] [Related]
35. [X-linked lymphoproliferative syndrome (XLP)].
Kawa K
Ryoikibetsu Shokogun Shirizu; 2000; (32):528-30. PubMed ID: 11212794
[No Abstract] [Full Text] [Related]
36. Pillars Article: The X-Linked Lymphoproliferative Disease Gene Product SAP Regulates Signals Induced through the Co-Receptor SLAM.
Sayos J; Wu C; Morra M; Wang N; Zhang X; Allen D; van Schaik S; Notarangelo L; Geha R; Roncarolo MG; Oettgen H; De Vries JE; Aversa G; Terhorst C
J Immunol; 2017 Sep; 199(5):1534-1541. PubMed ID: 28827385
[No Abstract] [Full Text] [Related]
37. [Lymphoproliferative disorders caused by hereditary genetic defects].
Kanegane H; Miyawaki T
Nihon Rinsho Meneki Gakkai Kaishi; 2003 Dec; 26(6):311-22. PubMed ID: 14752931
[No Abstract] [Full Text] [Related]
38. SLAM family receptors in normal immunity and immune pathologies.
Wu N; Veillette A
Curr Opin Immunol; 2016 Feb; 38():45-51. PubMed ID: 26682762
[TBL] [Abstract][Full Text] [Related]
39. A unique clinical presentation of X-linked lymphoproliferative syndrome with a novel mutation in SH2D1A and review of the literature.
Eckrich MJ; Yang E; Domm J; Ho R; Calder C; Manes B; Bleesing J; Frangoul H
J Pediatr Hematol Oncol; 2011 Jan; 33(1):e39-42. PubMed ID: 20975587
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
